The latest healthcare SPAC comes in at $200M with a laser focus on artificial intelligence

A new healthcare SPAC is expected to price during Friday’s session, and it’s one that wants to take advantage of the industry’s buzziest sector.

The blank check company will make a $200 million debut on Nasdaq, coming to the public market on the backs of Stanley Capital fundraising. This SPAC is not only targeting life sciences, but life sciences companies with a specific focus on artificial intelligence. One need not look past the name as evidence — Healthcare AI Acquisition Corp.